表紙
市場調查報告書
商品編碼
1027377

體外診斷 (IVD) 品管的全球市場 (∼2026年):各類型 (血漿、全血、尿)、技術 (免疫檢測、血液、微生物、分子診斷)、製造商 (第三方、OEM)、終端用戶 (醫院、實驗室)、地區

In Vitro Diagnostics (IVD) Quality Control Market, by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Molecular Diagnostics), Manufacturer (Third-party, OEM), End Users (Hospitals, Lab) - Global Forecast to 2026

出版日期: | 出版商: MarketsandMarkets | 英文 333 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球體外診斷 (IVD) 品管的市場規模在預測期間內預計以5.3%的年複合成長率發展,從2021年的11億美元,成長到2026年14億美元的規模。

IVD檢驗在臨床性的決策中發揮了重要作用。認定的臨床實驗室數增加,老年人口增加,外部品質評估計劃的需求高漲,在先進地區的POC設備的引進增加,第三方的品管的引進增加等要素促進該市場的成長。

本報告提供全球體外診斷 (IVD) 品管的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,技術、專利分析,市場規模的變化、預測,產品&服務、技術、製造商、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 市場成長要素
    • 市場阻礙因素
    • 市場機會
    • 市場課題
  • 產業趨勢
  • 價值鏈分析
  • 供應鏈分析
  • 生態系統
  • 波特的五力分析
  • 法規分析
  • COVID-19的影響
  • 專利分析
  • 技術分析

第6章 市場分析、預測:產品、各服務

  • 品管產品
    • 血清/血漿為基礎
    • 全血為基礎
    • 尿為基礎
    • 其他
  • 資料管理解決方案
  • 品質保證服務

第7章 市場分析、預測:各技術

  • 免疫化學
  • 臨床化學
  • 分子診斷
  • 微生物
  • 血液
  • 凝固、止血
  • 其他

第8章 市場分析、預測:各製造商

  • 第三方管理
    • 獨立型
    • 設備專用管理
  • OEM

第9章 市場分析、預測:各終端用戶

  • 醫院
  • 臨床實驗室
  • 學術、研究機關
  • 其他

第10章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第11章 競爭情形

  • 主要企業的策略
  • 主要企業的收益佔有率分析
  • 市場佔有率分析
  • 企業評估象限
  • R&D費
  • 新興企業的企業評估象限
  • 企業的產品足跡
  • 主要企業的地理足跡
  • 競爭模式

第12章 企業簡介

  • 主要企業
    • BIO-RAD LABORATORIES, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • RANDOX LABORATORIES LTD.
    • LGC LIMITED
    • ROCHE DIAGNOSTICS
    • ABBOTT LABORATORIES
    • SIEMENS HEALTHINEERS
    • QUIDEL CORPORATION
    • DANAHER CORPORATION
    • SYSMEX CORPORATION
    • ORTHO CLINICAL DIAGNOSTICS
    • BIO-TECHNE CORPORATION
    • SEEGENE INC.
    • QNOSTICS
    • MICROBIOLOGICS, INC.
    • ZEPTOMETRIX CORPORATION
    • FORTRESS DIAGNOSTICS
    • MICROBIX BIOSYSTEMS INC.
    • GRIFOLS, S.A.
    • ALPHA-TEC SYSTEMS, INC.
  • 其他的主要企業
    • HELENA LABORATORIES CORPORATION
    • STRECK, INC.
    • MAINE MOLECULAR QUALITY CONTROLS, INC.(MMQCI)
    • SUN DIAGNOSTICS, LLC
    • SERO AS

第13章 附錄

目錄
Product Code: MD 4180

The global IVD quality control market is projected to reach USD 1.4 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.3% during the forecast period. IVD testing plays a significant role in clinical decision-making. The growth of the IVD quality control market is primarily driven by the rising number of accredited clinical laboratories, rising geriatric population, rising demand for external quality assessment programs, increasing adoption of and POC instruments in developed regions and increasing adoption of third-party quality controls. The rising focus on multi-analyte controls is also expected to offer significant growth opportunities for the market in the coming years. The use of quality control products is, however, not mandatory for all clinical laboratories in many countries. The lack of regulations for these products is expected to adversely affect the market growth

The product & service segment holds the highest share of the total IVD quality control market during the forecast period.

Based on product & service, the IVD quality control market is segmented into quality control products, data management solutions, and quality assurance services. The quality control products segment accounted for the largest share of the IVD quality control market in 2020. The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies to ensure the accuracy of diagnostic test results are driving the growth of the IVD quality control products market.

Serum based controls drive the growth of the quality control products segment during the forecast period.

Based on type, the IVD quality control products market is segmented into serum/plasma-based controls, whole blood-based controls, urine-based controls, and others. Serum/plasma-based controls are highly preferred by laboratories; this segment accounted for the largest share of the quality control products market in 2020. The greater uptake of serum/plasma-based quality controls among laboratories and the wide application areas of these controls for various IVD tests are driving the market growth

Molecular diagnostics segment accounted for the highest CAGR of the global IVD quality control market

Based on technology, the IVD quality control market is broadly segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other technologies. The molecular diagnostics segment has the highest CAGR for the forecast period. With the increased non-communicable disease burden, molecular diagnostic tests have been used in the field of oncology widely. Technological advancement in the field of molecular diagnostics is another driver for the growth of this industry.

Third-party controls accounted for the highest share for the IVD quality control market

Based on manufacturer, the IVD quality control market is segmented into third-party controls and OEM controls. The third-party controls segment accounted for the largest share of the global IVD quality control market in 2020. The large share of this segment can be attributed to the increasing use of third-party quality controls across the globe to verify the accuracy and reliability of tests

Based on end users, hospitals accounted for the highest share of the global IVD quality control market during the forecast period.

The key end users of IVD quality controls studied in this report include hospitals, clinical laboratories, research & academic institutes, and other end users. The hospitals segment accounted for the largest share of the IVD quality control market in 2020, owing to the large volume of diagnostic tests carried out in hospitals.

North America is expected to account for the highest share for players operating in the global IVD quality control market

Geographically, the global IVD quality control market studied in this report is divided into five major regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global IVD quality control market, followed by Europe. The APAC region has the highest CAGR of the global IVD quality control market. The Asia Pacific is considered the most lucrative market for IVD quality controls, owing to the region's large patient population and rising healthcare needs. Market players are focusing on improving laboratory test quality in emerging APAC countries by working with local government bodies, agencies, and academic societies to offer external QC for standardizing laboratory testing procedures and ensure accuracy.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-60%, Tier 2-30%, and Tier 3-10%
  • By Designation - C-level-30%, Director-level-50%, Others-20%
  • By Region - North America-45%, Europe-15%, Asia Pacific-25%, Latin America- 10%, Middle East and Africa-5%

Key players in the IVD quality control Market

Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.

Research Coverage:

The report analyzes the IVD quality control market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, manufacturer type, end user, and region. The report also includes a product portfolio matrix of various IVD quality control available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global IVD quality control market. The report analyzes this market by product, technology, manufacturer type, end user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global IVD quality control market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, technology, manufacturer type, end user, and region.
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global IVD quality control market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global IVD quality control market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
    • 1.3.3 CURRENCY
    • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND- SIDE PARTICIPANTS
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BIO-RAD LABORATORIES, INC.
    • FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: IVD QUALITY CONTROL MARKET (2020)
    • FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE IVD QUALITY CONTROL MARKET (2021-2026)
    • FIGURE 9 CAGR PROJECTIONS
    • FIGURE 10 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: IVD QUALITY CONTROL MARKET
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 12 IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 IVD QUALITY CONTROL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 18 IVD QUALITY CONTROL MARKET: GEOGRAPHIC SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 IVD QUALITY CONTROL MARKET OVERVIEW
    • FIGURE 19 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET GROWTH
  • 4.2 APAC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY AND COUNTRY (2020)
    • FIGURE 20 IMMUNOCHEMISTRY TO COMMAND THE LARGEST SHARE OF THE APAC IVD QUALITY CONTROL MARKET IN 2020
  • 4.3 IVD QUALITY CONTROL MARKET: GEOGRAPHIC MIX
    • FIGURE 21 CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 4.4 IVD QUALITY CONTROL MARKET: DEVELOPED VS DEVELOPING MARKETS
    • FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 MARKET DYNAMICS
    • FIGURE 23 IVD QUALITY CONTROL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.1.1 MARKET DRIVERS
      • 5.1.1.1 Increasing number of accredited clinical laboratories
    • FIGURE 24 US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (2018)
      • 5.1.1.2 Growing adoption of third-party quality controls
      • 5.1.1.3 Rising demand for external quality assessment support
      • 5.1.1.4 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases
    • TABLE 3 ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION (2019-2050)
    • FIGURE 25 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040
    • FIGURE 26 GLOBAL CANCER INCIDENCE, 2015-2040
      • 5.1.1.5 Increasing adoption of POC instruments in developed regions
    • TABLE 4 MARKET DRIVERS: IMPACT ANALYSIS
    • 5.1.2 MARKET RESTRAINTS
      • 5.1.2.1 Additional costs and budget constraints in hospitals and laboratories
      • 5.1.2.2 Unfavorable reimbursement scenario for IVD tests
    • TABLE 5 MARKET RESTRAINTS: IMPACT ANALYSIS
    • 5.1.3 MARKET OPPORTUNITIES
      • 5.1.3.1 Rising demand for multi-analyte controls
    • TABLE 6 MARKET OPPORTUNITIES: IMPACT ANALYSIS
    • 5.1.4 MARKET CHALLENGES
      • 5.1.4.1 Stringent product approval process
      • 5.1.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries
    • TABLE 7 MARKET CHALLENGES: IMPACT ANALYSIS
  • 5.2 INDUSTRY TRENDS
    • 5.2.1 LYOPHILIZED/FREEZE-DRIED CONTROLS
    • TABLE 8 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
    • 5.2.2 TRENDS ON ANALYTE SOURCE: HUMAN VS. ANIMAL ORIGIN
    • 5.2.3 CONSOLIDATION OF LABORATORIES
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 27 IVD QUALITY CONTROL MARKET: VALUE CHAIN ANALYSIS
  • 5.4 SUPPLY CHAIN ANALYSIS
    • FIGURE 28 IVD QUALITY CONTROL MARKET: SUPPLY CHAIN ANALYSIS
  • 5.5 ECOSYSTEM MARKET MAP
    • FIGURE 29 IVD QUALITY CONTROL MARKET: ECOSYSTEM MARKET MAP
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT FROM NEW ENTRANTS
    • 5.6.2 THREAT FROM SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 REGULATORY ANALYSIS
    • 5.7.1 NORTH AMERICA
      • 5.7.1.1 US
    • TABLE 9 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
    • TABLE 10 US: TIME, COST, AND COMPLEXITY OF REGISTRATION
      • 5.7.1.2 Canada
    • TABLE 11 CANADA: CLASSIFICATION OF IVD PRODUCTS
    • TABLE 12 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
    • 5.7.2 EUROPE
    • TABLE 13 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
    • TABLE 14 EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION
    • 5.7.3 ASIA PACIFIC
      • 5.7.3.1 Japan
    • TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
      • 5.7.3.2 China
    • TABLE 16 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
      • 5.7.3.3 India
    • TABLE 17 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION
  • 5.8 IMPACT OF COVID-19 ON THE IVD QUALITY CONTROL MARKET
    • FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS
    • FIGURE 31 ROCHE DIAGNOSTICS.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS
    • FIGURE 32 BIO-RAD LABORATORIES, INC.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS
    • FIGURE 33 ABBOTT LABORATORIES: COVID-19 IMPACT ON SEGMENTAL ANALYSIS
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT PUBLICATION TRENDS FOR IVD QUALITY CONTROLS
    • FIGURE 34 PATENT PUBLICATION TRENDS (2011-AUGUST 2021)
    • 5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 35 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR IVD QUALITY CONTROL PATENTS (JANUARY 2011-AUGUST 2021)
    • FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR IVD QUALITY CONTROL PATENTS (JANUARY 2011-AUGUST 2021)
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 KEY TECHNOLOGIES
      • 5.10.1.1 Analyte extraction
        • 5.10.1.1.1 Specimen pooling
        • 5.10.1.1.2 Human monoclonals
      • 5.10.1.2 Specimen processing
        • 5.10.1.2.1 Inactivation
        • 5.10.1.2.2 Dilution
      • 5.10.1.3 Preservation
    • 5.10.2 ADJACENT TECHNOLOGIES
      • 5.10.2.1 Sensor-based quality control
    • 5.10.3 COMPLEMENTARY TECHNOLOGIES
      • 5.10.3.1 Storage
      • 5.10.3.2 Transport
      • 5.10.3.3 Temperature control
      • 5.10.3.4 Temperature monitoring

6 IVD QUALITY CONTROL MARKET, BY PRODUCT AND SERVICE

  • 6.1 INTRODUCTION
    • TABLE 18 IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
  • 6.2 QUALITY CONTROL PRODUCTS
    • TABLE 19 QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 20 QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.1 SERUM/PLASMA-BASED CONTROLS
      • 6.2.1.1 Greater stability and accuracy of diagnostic test results to increase the demand for serum/plasma-based controls
    • TABLE 21 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 22 SERUM/PLASMA-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.2 WHOLE BLOOD-BASED CONTROLS
      • 6.2.2.1 Rising need to ensure high-quality clinical test results to drive the whole blood-based controls market
    • TABLE 23 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 24 WHOLE BLOOD-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.3 URINE-BASED CONTROLS
      • 6.2.3.1 The growing incidence of kidney diseases increase the need for urine-based controls
    • TABLE 25 URINE-BASED IVD CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 26 URINE-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.4 OTHER CONTROLS
    • TABLE 27 OTHER CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 28 OTHER QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.3 DATA MANAGEMENT SOLUTIONS
    • 6.3.1 RISING FOCUS ON IMPROVING THE ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH
    • TABLE 29 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS
    • TABLE 30 DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.4 QUALITY ASSURANCE SERVICES
    • 6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE THE DEMAND FOR QUALITY ASSURANCE SERVICES
    • TABLE 31 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS
    • TABLE 32 QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

7 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 33 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
  • 7.2 IMMUNOCHEMISTRY
    • 7.2.1 FOCUS ON MONITORING THE PRECISION OF IMMUNOASSAY TESTS TO DRIVE THE ADOPTION OF IMMUNOASSAY CONTROLS
    • TABLE 34 QUALITY CONTROLS FOR IMMUNOCHEMISTRY OFFERED BY KEY MARKET PLAYERS
    • TABLE 35 IVD QUALITY CONTROL MARKET FOR IMMUNOCHEMISTRY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 CLINICAL CHEMISTRY
    • 7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH
    • TABLE 36 QUALITY CONTROLS FOR CLINICAL CHEMISTRY OFFERED BY KEY MARKET PLAYERS
    • TABLE 37 IVD QUALITY CONTROL MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 MOLECULAR DIAGNOSTICS
    • 7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS
    • TABLE 38 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS
    • TABLE 39 IVD QUALITY CONTROL MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.5 MICROBIOLOGY
    • 7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH
    • TABLE 40 QUALITY CONTROLS FOR MICROBIOLOGY OFFERED BY KEY MARKET PLAYERS
    • TABLE 41 IVD QUALITY CONTROL MARKET FOR MICROBIOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.6 HEMATOLOGY
    • 7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS
    • TABLE 42 QUALITY CONTROLS FOR HEMATOLOGY OFFERED BY KEY MARKET PLAYERS
    • TABLE 43 IVD QUALITY CONTROL MARKET FOR HEMATOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.7 COAGULATION & HEMOSTASIS
    • 7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE THE NEED FOR COAGULATION & HEMOSTASIS TESTING
    • TABLE 44 QUALITY CONTROLS FOR COAGULATION & HEMOSTASIS OFFERED BY KEY MARKET PLAYERS
    • TABLE 45 IVD QUALITY CONTROL MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.8 OTHER TECHNOLOGIES
    • TABLE 46 QUALITY CONTROLS FOR OTHER TECHNOLOGIES OFFERED BY KEY MARKET PLAYERS
    • TABLE 47 IVD QUALITY CONTROL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019-2026 (USD MILLION)

8 IVD QUALITY CONTROL MARKET, BY MANUFACTURER

  • 8.1 INTRODUCTION
    • TABLE 48 IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
  • 8.2 THIRD-PARTY CONTROLS
    • TABLE 49 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 50 THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 8.2.1 INDEPENDENT CONTROLS
      • 8.2.1.1 Increased preference for independent controls to fuel market growth
    • TABLE 51 INDEPENDENT CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 52 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 8.2.2 INSTRUMENT-SPECIFIC CONTROLS
      • 8.2.2.1 Usage limitations to subdue market growth rate in favor of independent controls
    • TABLE 53 INSTRUMENT-SPECIFIC CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 54 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS
    • 8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES
    • TABLE 55 OEM CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 56 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

9 IVD QUALITY CONTROL MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 57 IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 HOSPITALS
    • 9.2.1 HUGE VOLUME OF IVD PROCEDURES PERFORMED IN HOSPITALS TO DRIVE MARKET GROWTH
    • TABLE 58 IVD QUALITY CONTROL MARKET FOR HOSPITALS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 CLINICAL LABORATORIES
    • 9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE THE MARKET
    • TABLE 59 IVD QUALITY CONTROL MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.4 ACADEMIC AND RESEARCH INSTITUTES
    • 9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET GROWTH
    • TABLE 60 IVD QUALITY CONTROL MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 61 IVD QUALITY CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)

10 IVD QUALITY CONTROL MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 62 IVD QUALITY CONTROL MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 63 IVD QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 37 NORTH AMERICA: IVD QUALITY CONTROL MARKET SNAPSHOT
    • TABLE 64 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 65 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 66 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 67 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 68 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 69 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 High healthcare expenditure in the country and the implementation of mandatory laboratory accreditation and quality assurance guidelines in laboratories to drive market growth in the US
    • TABLE 71 US: KEY MACROINDICATORS
    • TABLE 72 US: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 73 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 74 US: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 75 US: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 76 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 77 US: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Government initiatives to promote quality controls to drive market growth in Canada
    • TABLE 78 CANADA: KEY MACROINDICATORS
    • TABLE 79 CANADA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 80 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 81 CANADA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 82 CANADA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 83 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 CANADA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 85 EUROPE: IVD QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 86 EUROPE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 87 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 EUROPE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 89 EUROPE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 90 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 EUROPE: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Increasing number of certified laboratories and the rising volume of high-quality tests performed by these laboratories to support market growth in Germany
    • TABLE 92 GERMANY: KEY MACROINDICATORS
    • TABLE 93 GERMANY: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 94 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 95 GERMANY: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 96 GERMANY: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 97 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 GERMANY: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market growth
    • TABLE 99 FRANCE: KEY MACROINDICATORS
    • TABLE 100 FRANCE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 101 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 FRANCE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 103 FRANCE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 104 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 FRANCE: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Growth in the life science industry and increased research to drive market growth in the UK
    • TABLE 106 UK: KEY MACROINDICATORS
    • TABLE 107 UK: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 108 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 UK: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 110 UK: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 111 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 UK: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Growing disease prevalence to drive the demand for better and more accurate disease diagnosis in Italy
    • TABLE 113 ITALY: KEY MACROINDICATORS
    • TABLE 114 ITALY: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 115 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 ITALY: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 117 ITALY: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 118 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 ITALY: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing demand for prenatal and genetic testing and rising focus on laboratory consolidation to support market growth in Spain
    • TABLE 120 SPAIN: KEY MACROINDICATORS
    • TABLE 121 SPAIN: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 122 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 SPAIN: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 124 SPAIN: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 125 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 SPAIN: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.6 RUSSIA
      • 10.3.6.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market growth in Russia
    • TABLE 127 RUSSIA: KEY MACRO INDICATORS
    • TABLE 128 RUSSIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 129 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 RUSSIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 131 RUSSIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 132 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 133 RUSSIA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 134 ROE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 135 ROE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 136 ROE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 137 ROE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 138 ROE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 ROE: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 38 ASIA PACIFIC: IVD QUALITY CONTROL MARKET SNAPSHOT
    • TABLE 140 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 144 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 145 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Well-developed healthcare system and the rising demand for improvements in the quality of IVD test results to drive market growth in Japan
    • TABLE 147 JAPAN: KEY MACROINDICATORS
    • TABLE 148 JAPAN: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 149 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 JAPAN: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 151 JAPAN: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 152 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 153 JAPAN: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Growing access to modern healthcare and government support to boost the market growth in China
    • TABLE 154 CHINA: KEY MACROINDICATORS
    • TABLE 155 CHINA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 156 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 157 CHINA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 158 CHINA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 159 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 CHINA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Rising need to secure NABL accreditations to drive the demand for quality controls in India
    • FIGURE 39 INDIA: INCREASING NUMBER OF LABS WITH NABL ACCREDITATIONS, 2012-2020
    • TABLE 161 INDIA: KEY MACROINDICATORS
    • TABLE 162 INDIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 163 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 164 INDIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 165 INDIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 166 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 INDIA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Growing geriatric population has resulted in initiatives to enhance access to healthcare and improve infrastructure
    • TABLE 168 AUSTRALIA: KEY MACROINDICATORS
    • TABLE 169 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 170 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 172 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 173 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 174 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Rising healthcare expenditure and the growing number of hospitals to drive the growth of the South Korean market
    • TABLE 175 SOUTH KOREA: KEY MACROINDICATORS
    • TABLE 176 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 177 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 179 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 180 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 181 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 182 ROAPAC: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 183 ROAPAC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 184 ROAPAC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 185 ROAPAC: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 186 ROAPAC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 187 ROAPAC: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 188 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 189 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 190 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 191 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 192 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 193 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 194 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil dominates the Latin American IVD quality control market
    • TABLE 195 BRAZIL: KEY MACROINDICATORS
    • TABLE 196 BRAZIL: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 197 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 198 BRAZIL: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 199 BRAZIL: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 200 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 201 BRAZIL: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Mexico is emerging as a prominent medical tourism hub
    • TABLE 202 MEXICO: KEY MACROINDICATORS
    • TABLE 203 MEXICO: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 204 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 205 MEXICO: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 206 MEXICO: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 207 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 208 MEXICO: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 209 ROLA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 210 ROLA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 211 ROLA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 212 ROLA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 213 ROLA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 214 ROLA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 RISING CANCER INCIDENCE HAS ATTRACTED STAKEHOLDER ATTENTION TO REGIONAL MARKETS IN MEA
    • TABLE 215 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 216 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 217 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 218 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019-2026 (USD MILLION)
    • TABLE 219 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 220 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
  • 11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE IVD QUALITY CONTROL MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 41 IVD QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2020
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 42 IVD QUALITY CONTROL MARKET: COMPANY EVALUATION QUADRANT (2020)
  • 11.6 R&D EXPENDITURE
    • FIGURE 43 IVD QUALITY CONTROL MARKET: R&D EXPENDITURE (IN USD MILLION), 2020
  • 11.7 COMPANY EVALUATION QUADRANT FOR START-UPS
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 DYNAMIC COMPANIES
    • 11.7.3 STARTING BLOCKS
    • 11.7.4 RESPONSIVE COMPANIES
    • FIGURE 44 IVD QUALITY CONTROL MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)
  • 11.8 COMPANY PRODUCT FOOTPRINT
    • TABLE 221 PRODUCT PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET
    • FIGURE 45 TECHNOLOGY PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET
    • TABLE 222 MANUFACTURER TYPE PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET
    • TABLE 223 END-USER PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET
  • 11.9 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE IVD QUALITY CONTROL MARKET
    • TABLE 224 GEOGRAPHIC REVENUE MIX: IVD QUALITY CONTROL MARKET (2020)
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT LAUNCHES
    • TABLE 225 PRODUCT LAUNCHES
    • 11.10.2 DEALS
    • TABLE 226 DEALS
    • 11.10.3 OTHER DEVELOPMENTS
    • TABLE 227 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS

(Business overview, Products and Services offered, Recent developments, SWOT analysis, MNM view)**

    • 12.1.1 BIO-RAD LABORATORIES, INC.
    • TABLE 228 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 46 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
    • 12.1.2 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 229 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 47 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
    • 12.1.3 RANDOX LABORATORIES LTD.
    • TABLE 230 RANDOX LABORATORIES: BUSINESS OVERVIEW
    • 12.1.4 LGC LIMITED
    • TABLE 231 LGC LIMITED: BUSINESS OVERVIEW
    • FIGURE 48 LGC LIMITED: COMPANY SNAPSHOT
    • 12.1.5 ROCHE DIAGNOSTICS
    • TABLE 232 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
    • FIGURE 49 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2020)
    • 12.1.6 ABBOTT LABORATORIES
    • TABLE 233 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
    • 12.1.7 SIEMENS HEALTHINEERS
    • TABLE 234 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
    • FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
    • 12.1.8 QUIDEL CORPORATION
    • TABLE 235 QUIDEL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 52 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.9 DANAHER CORPORATION
    • TABLE 236 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 53 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.10 SYSMEX CORPORATION
    • TABLE 237 SYSMEX CORPORATION: BUSINESS OVERVIEW
    • FIGURE 54 SYSMEX CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.11 ORTHO CLINICAL DIAGNOSTICS
    • TABLE 238 ORTHO CLINICAL DIAGNOSTICS: BUSINESS OVERVIEW
    • FIGURE 55 ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT (2020)
    • 12.1.12 BIO-TECHNE CORPORATION
    • TABLE 239 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
    • FIGURE 56 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.13 SEEGENE INC.
    • TABLE 240 SEEGENE INC.: BUSINESS OVERVIEW
    • FIGURE 57 SEEGENE INC: COMPANY SNAPSHOT (2020)
    • 12.1.14 QNOSTICS
    • TABLE 241 QNOSTICS: BUSINESS OVERVIEW
    • 12.1.15 MICROBIOLOGICS, INC.
    • TABLE 242 MICROBIOLOGICS: BUSINESS OVERVIEW
    • 12.1.16 ZEPTOMETRIX CORPORATION
    • TABLE 243 ZEPTOMETRIX CORPORATION: BUSINESS OVERVIEW
    • 12.1.17 FORTRESS DIAGNOSTICS
    • TABLE 244 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW
    • 12.1.18 MICROBIX BIOSYSTEMS INC.
    • TABLE 245 MICROBIX BIOSYSTEMS: BUSINESS OVERVIEW
    • FIGURE 58 MICROBIX BIOSYSTEMS: COMPANY SNAPSHOT
    • 12.1.19 GRIFOLS, S.A.
    • TABLE 246 GRIFOLS, S.A.: BUSINESS OVERVIEW
    • FIGURE 59 GRIFOLS, S.A.: COMPANY SNAPSHOT
    • 12.1.20 ALPHA-TEC SYSTEMS, INC.
    • TABLE 247 ALPHA-TEC SYSTEMS, INC.: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 HELENA LABORATORIES CORPORATION
    • TABLE 248 HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW
    • 12.2.2 STRECK, INC.
    • TABLE 249 STRECK: BUSINESS OVERVIEW
    • 12.2.3 MAINE MOLECULAR QUALITY CONTROLS, INC. (MMQCI)
    • TABLE 250 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW
    • 12.2.4 SUN DIAGNOSTICS, LLC
    • TABLE 251 SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW
    • 12.2.5 SERO AS
    • TABLE 252 SERO AS: BUSINESS OVERVIEW
  • *Business overview, Products and Services offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS